NATCO Pharma Limited announces the launch of additional strengths for the generic version of Revlimid (lenalidomide capsules), in 2.5 mg, and 20 mg strengths, in the United States, via an exchange filing.
The launch is through its marketing partner Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd.
With this launch the companies made available all the strengths of lenalidomide in the US market.
Lenalidomide capsules are a prescription medicine used in adults for the treatment of multiple myeloma.
Exclusive: Dabang Delhi Skipper Ashu Malik Gives His Take On Team Dynamics During PKL 2025 Season, Says 'There's No Junior-Senior Thing'
Mumbai Tragedy: 20-Year-Old Aspiring Kabaddi Player Dies By Suicide In Bandra, Allegedly Due To Chronic Leg Pain
Bhiwandi Accident: 32-Year-Old Biker Dies After Being Thrown Off Bridge In Collision Involving 2 Cars
Mumbai News: BMC Restores Patient Registration Services At Vile Parle's Cooper Hospital After Manpower Shortage
